Position in ZTS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$66,098,479
-$77,423,000 QoQ
Shares Held
919,823
-24.2% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#76
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $220,070,795 across 11 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (30.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
919,823 | $66,098,479 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
5,310,871 | $53,108,710 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
403,485 | $25,802,865 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
271,760 | $22,496,292 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
453,206 | $21,078,610 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
737,670 | $13,248,553 | |
| 7 | ALKS |
Alkermes plc.
|
193,805 | $10,154,412 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
22,955 | $3,868,835 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,098,479 | 919,823 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $143,521,479 | 1,214,123 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $149,520,838 | 1,188,371 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $162,290,973 | 1,109,151 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $180,216,443 | 1,155,604 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $180,515,508 | 1,096,359 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $180,106,080 | 1,105,420 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $226,147,464 | 1,157,475 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $205,234,142 | 1,183,861 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $184,646,858 | 1,091,229 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $202,367,013 | 1,025,318 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $135,010,219 | 776,010 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $124,379,360 | 722,254 | Shares | Defined | 2024-06-20 | |
| 2023-03-31 | $92,887,334 | 558,083 | Shares | Defined | 2024-06-20 | |
| 2022-12-31 | $73,827,346 | 503,769 | Shares | Defined | 2024-06-20 | |
| 2022-09-30 | $69,387,411 | 467,917 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $33,085,385 | 192,480 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $30,623,053 | 162,379 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $41,615,167 | 170,533 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $34,311,138 | 176,734 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $30,692,373 | 164,694 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $26,971,913 | 171,272 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $26,557,288 | 160,467 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $25,360,811 | 153,358 | Shares | Defined | 2020-10-21 | |
| 2020-06-30 | $23,940,201 | 174,695 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $22,083,703 | 187,643 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||